# Comparison Between Symbicort® and Prednisolone in COPD

> **NCT00259779** · PHASE3 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 120 (estimated)

## Conditions studied

- Chronic Obstructive Pulmonary Disease

## Interventions

- **DRUG:** budesonide/formoterol
- **DRUG:** Prednisolone

## Key facts

- **NCT ID:** NCT00259779
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-09
- **Primary completion:** —
- **Final completion:** 2007-07
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2011-01-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00259779

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00259779, "Comparison Between Symbicort® and Prednisolone in COPD". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00259779. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*